earnings

The Big Winner for Johnson & Johnson in Q1
Motley Fool
Tue, 05/4/21 - 10:36 am
JNJ
earnings
devices
pandemic
vaccines
COVID-19
AbbVie Rises on Q1 Beats, Raised EPS Guidance
Motley Fool
Sat, 05/1/21 - 09:21 pm
AbbVie
earnings
Gilead's Q1 Results Show Just How Much the Biotech Is Relying on Its COVID Drug
Motley Fool
Fri, 04/30/21 - 10:34 am
Gilead Sciences
earnings
AZ posts solid Q1 results as Alexion merger looms
Pharmforum
Fri, 04/30/21 - 10:27 am
AstraZeneca
M&A
Alexion
vaccines
earnings
After $600M sales hit from pandemic, Merck's open to 'all forms' of M&A deals, incoming CEO says
Fierce Pharma
Thu, 04/29/21 - 11:06 pm
Merck
M&A
earnings
Bristol Myers first-quarter earnings miss expectations as cancer drugs underperform
Reuters
Thu, 04/29/21 - 10:57 pm
Bristol Myers Squibb
earnings
Merck, GSK vaccine sales hit by pandemic as competitors' business booms
BioPharma Dive
Thu, 04/29/21 - 10:42 pm
Merck
GSK
earnings
Merck Stock Dives As Pandemic Bungles First-Quarter Sales, Earnings
Investors Business Daily
Thu, 04/29/21 - 10:40 pm
Merck
earnings
Thermo Fisher has flourished amid the pandemic, but can it keep the ball rolling when Covid-19 comes to a close?
Endpoints
Thu, 04/29/21 - 10:38 pm
Thermo Fisher
earnings
CDMOs
What Went Wrong for Bristol Myers Squibb in Q1
Motley Fool
Thu, 04/29/21 - 10:53 am
Bristol Myers Squibb
earnings
GlaxoSmithKline focuses on split after lacklustre Q1 results
Pharmaforum
Thu, 04/29/21 - 10:41 am
GSK
consumer health
earnings
reorganization
Boston Scientific sees Q1 electives rebound, hints at further 2021 M&A
Medtech Dive
Wed, 04/28/21 - 10:10 pm
Boston Scientific
earnings
devices
Sanofi reports sales growth amid Dupixent's China launch, but reveals PDUFA delay in Pompe disease program
Endpoints
Wed, 04/28/21 - 10:30 am
Sanofi
earnings
China
Dupixent
Pompe disease
How Illumina's Q1 Results Delighted Investors
Motley Fool
Wed, 04/28/21 - 10:25 am
Illumina
earnings
diagnostics
gene sequencing
Why Amgen's Q1 Results Disappointed Investors
Motley Fool
Wed, 04/28/21 - 10:18 am
Amgen
earnings
GSK focused on split as cost checks, COVID-19 easings aid earnings
Reuters
Wed, 04/28/21 - 10:17 am
GSK
earnings
Novartis Generics Face 'Challenging Quarter,' But Gene Therapy Shines
Investors Business Daily
Tue, 04/27/21 - 11:20 pm
Novartis
earnings
Eli Lilly Stock Crumbles As Covid Antibodies Hammer Sales, 2021 Outlook
Investors Business Daily
Tue, 04/27/21 - 10:51 am
earnings
Eli Lilly
Why Biogen's Better-Than-Expected Q1 Results Weren't Good Enough
Motley Fool
Thu, 04/22/21 - 11:09 am
Biogen
earnings
Roche sees a slight dip in Q1 as biosim­i­lars keep bit­ing in­to block­buster on­col­o­gy tri­o's sales
Endpoints
Wed, 04/21/21 - 10:40 am
Roche
earnings
biosimilars

Pages